Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
06.05.2024 |
03.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.015
|
|
0.03
|
0.03
|
0.03
|
0.03
|
|
|
|
1.00
|
0.0251
|
0.0436
|
0.035
|
0.035
|
0.035
|
0.035
|
|
|
|
1.00
|
0.0151
|
0.0436
|
0.0289
|
0.0289
|
0.029216
|
0.029216
|
|
|
0.14
|
3.00
|
0.0251
|
0.0436
|
0.04
|
0.029216
|
0.04
|
0.029216
|
|
|
9.57
|
6.00
|
0.0252
|
0.0437
|
0.038
|
0.038
|
0.038
|
0.038
|
|
|
|
1.00
|
0.015
|
0.0998
|
0.0349
|
0.03
|
0.0349
|
0.03
|
|
|
0.39
|
4.00
|
0.0301
|
|
0.038876
|
0.038876
|
0.038876
|
0.038876
|
|
|
|
1.00
|
0.0251
|
0.0495
|
0.0432
|
0.042
|
0.0432
|
0.042
|
|
|
86.40
|
3.00
|
0.025
|
0.0583
|
0.05
|
0.05
|
0.05
|
0.05
|
|
|
499.75
|
5.00
|
0.005
|
0.06
|
0.0519
|
0.042978
|
0.0519
|
0.042978
|
|
|
0.0519
|
3.00
|
Aclarion, Inc. operates as a healthcare technology company. The Company offers magnetic resonance spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments, as well as utilizes artificial intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. Aclarion serves customers in the United States.